861 - Ending Neglect of Tropical Diseases
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.8 • 620 Ratings
🗓️ 4 March 2025
⏱️ 15 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Summary
About this episode:
Neglected diseases like mycetoma, Chagas disease, and leishmaniasis impact more than a billion people worldwide every year and kill hundreds of thousands. In this episode: Why these illnesses don’t get widespread attention or the resources needed for prevention, diagnosis and treatment, and how in a shifting global funding landscape, cross-sector collaboration is key to alleviating suffering.
Guests:
Delali Attipoe is the North America director of the Drugs for Neglected Disease initiative (DNDi).
Host:
Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:
-
Chagas: The Most Neglected of Neglected Tropical Diseases—Johns Hopkins Bloomberg School of Public Health
-
Neglected Diseases and Public Health—Johns Hopkins Bloomberg School of Public Health
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health, |
| 0:05.9 | where we bring evidence, experience, and perspective to make sense of today's leading health challenges. |
| 0:16.3 | If you have questions or ideas for us, please send an email to public health question at jh.h.u.edu. |
| 0:23.8 | That's public health question at jh.u.edu for future podcast episodes. |
| 0:31.5 | This is Lindsay Smith Rogers. |
| 0:33.7 | Today, Stephanie Desmond talks to Delali Adipo from the nonprofit medical research organization |
| 0:38.8 | Drugs for Neglected Diseases Initiative, or DNDDI. |
| 0:43.3 | They discussed neglected tropical diseases, parasitic and bacterial diseases that impact one in five people on the planet. |
| 0:50.8 | The work her organization does to develop suitable treatments and why we're seeing an uptick |
| 0:55.6 | in these tropical diseases in the United States. Let's listen. DeLali Atchapo, thanks so much for |
| 1:01.4 | joining me. Thank you, Stephanie. So you are the head of North American branch of an organization |
| 1:08.8 | called DNDI. And I'd love it if you could tell our listeners about, |
| 1:13.0 | briefly about your organization. Well, I think one of the things we'll first start with is, what |
| 1:16.7 | is D&I and what does it even stand for, right? So DNDDI stands for drugs for the neglected |
| 1:21.9 | diseases initiative. And so we're a non-for-profit organization that's really focused on how do we discover, as well |
| 1:28.7 | as develop treatments that are really needed for neglected disease areas and for those populations |
| 1:33.5 | that would benefit from them. And you're going to have to, if you don't mind, what are neglected |
| 1:38.5 | diseases? Neglected diseases actually affect around 1.65 million or billion actually people around the world. |
| 1:46.0 | And so it's a little bit of a misnomer sometimes when we call neglected tropical diseases, |
| 1:50.5 | which is what NTD stand for, to say that it's neglected. But it's really neglected because we don't |
| 1:55.7 | really have a number of treatments when you think about traditional drug development, R&D or research and development |
| 2:03.1 | that's done for disease areas, they're typically not focused on. And so one of the areas and |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.